Overview

Safety and Tolerability of NTRX-07 in Healthy Volunteers

Status:
Active, not recruiting
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
Randomized, placebo-controlled, modified parallel-design single ascending dose (SAD) in adult healthy volunteers (HVs).
Phase:
Phase 1
Details
Lead Sponsor:
NeuroTherapia, Inc.
Collaborators:
Integrium
Orange County Research Center